VeriMomtroxerutin est-il sûr pendant la grossesse ?
Human epidemiological data (population case–control) linking oral hydroxyethylrutoside treatment during early pregnancy to increased risk of specific congenital abnormalities supports a 'suspected' reproductive hazard (see Pósfai et al. 2014). No harmonised CLP/SCCS/CIR reproductive classification for troxerutin was found. For topical cosmetic use dermal systemic exposure is expected to be negligible given troxerutin's high molecular weight and hydrophilicity, so exposure from cosmetics is rated negligible.
Alternatives sûres à troxerutin pendant la grossesse | VeriMom
Related ingredients
Frequently asked questions
- troxerutin est-il sûr pendant la grossesse ?
- Human epidemiological data (population case–control) linking oral hydroxyethylrutoside treatment during early pregnancy to increased risk of specific congenital abnormalities supports a 'suspected' reproductive hazard (see Pósfai et al. 2014). No harmonised CLP/SCCS/CIR reproductive classification for troxerutin was found. For topical cosmetic use dermal systemic exposure is expected to be negligible given troxerutin's high molecular weight and hydrophilicity, so exposure from cosmetics is rated negligible.
- troxerutin est-il sûr pendant l'allaitement ?
- Animal reports indicate traces of hydroxyethylrutosides can be found in milk after systemic (oral) dosing; combined with the human epidemiology above this supports a suspected hazard for systemic use. For topical cosmetic use in the mother, systemic absorption is expected to be negligible and transfer via breast milk from topical use is considered negligible.
- troxerutin est-il sûr pour la peau de bébé ?
- Hazard is retained (suspected) because evidence exists for reproductive/ developmental effects with systemic exposures to hydroxyethylrutosides. Mechanistic reproductive toxicity data specific to troxerutin were not found. Dermal absorption from cosmetic use is expected to be very low in adults (e=0), but infant (0–3 yr) skin has increased permeability and higher surface-area-to-weight, so exposure is increased by +1 (e=1) compared with adults despite limited direct absorption data.
- Comment VeriMom évalue-t-il troxerutin ?
- VeriMom évalue troxerutin à 60/100 (risque moyen) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à troxerutin pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à troxerutin basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.